These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37783397)

  • 1. Utility of glutaraldehyde-fixed turkey red blood cells for influenza virus detection after 18 months of storage.
    Pawar SD; Tare DS; Kode SS; Keng SS
    J Virol Methods; 2023 Dec; 322():114830. PubMed ID: 37783397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of frozen and stored glutaraldehyde-fixed turkey red blood cells for hemagglutination and hemagglutination inhibition assays for the detection and identification of influenza viruses.
    Kode SS; Pawar SD; Tare DS; Mullick J
    J Virol Methods; 2021 Mar; 289():114046. PubMed ID: 33333106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor specificity and erythrocyte binding preferences of avian influenza viruses isolated from India.
    Pawar SD; Parkhi SS; Koratkar SS; Mishra AC
    Virol J; 2012 Oct; 9():251. PubMed ID: 23110802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte binding preference of human pandemic influenza virus a and its effect on antibody response detection.
    Makkoch J; Prachayangprecha S; Payungporn S; Chieochansin T; Songserm T; Amonsin A; Poovorawan Y
    Ann Lab Med; 2012 Jul; 32(4):276-82. PubMed ID: 22779069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits.
    Zhu H; Ding X; Chen X; Yao P; Xu F; Xie R; Yang Z; Liang W; Zhang Y; Li Y; Shen J; He P; Guo Z; Su B; Sun S; Zhu Z
    Vaccine; 2011 Jul; 29(33):5421-3. PubMed ID: 21645575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turkey versus guinea pig red blood cells: hemagglutination differences alter hemagglutination inhibition responses against influenza A/H1N1.
    Ovsyannikova IG; White SJ; Albrecht RA; García-Sastre A; Poland GA
    Viral Immunol; 2014 May; 27(4):174-8. PubMed ID: 24787023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study.
    Waldock J; Zheng L; Remarque EJ; Civet A; Hu B; Jalloh SL; Cox RJ; Ho S; Hoschler K; Ollinger T; Trombetta CM; Engelhardt OG; Caillet C
    mSphere; 2021 Aug; 6(4):e0056721. PubMed ID: 34319129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuraminidase (NA) 370-Loop Mutations of the 2009 Pandemic H1N1 Viruses Affect NA Enzyme Activity, Hemagglutination Titer, Mouse Virulence, and Inactivated-Virus Immunogenicity.
    Chen TH; Chen CC; Wu SC
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparability of Titers of Antibodies against Seasonal Influenza Virus Strains as Determined by Hemagglutination Inhibition and Microneutralization Assays.
    Heeringa M; Leav B; Smolenov I; Palladino G; Isakov L; Matassa V
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32493784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and Characterization of Monoclonal Antibodies Specific to Avian Influenza H5N1 Hemagglutinin Protein.
    Malik A; Mallajosyula VV; Mishra NN; Varadarajan R; Gupta SK
    Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):436-41. PubMed ID: 26683184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Hemagglutination Inhibition Titers against Influenza Vaccine Strains in Japan from the 2017/2018 to 2021/2022 Seasons Using a Single Set of Serum Samples.
    Otani N; Nakajima K; Ishikawa K; Ichiki K; Yoda Y; Ueda T; Takesue Y; Yamamoto T; Tanimura S; Shima M; Okuno T
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients.
    Kositanont U; Wongsurakiat P; Pooruk P; Maranetra N; Puthavathana P
    Viral Immunol; 2010 Jun; 23(3):329-34. PubMed ID: 20565296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses.
    Reneer ZB; Skarlupka AL; Jamieson PJ; Ross TM
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33692193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza A(H1N1)pdm09 But Not A(H3N2) Virus Infection Induces Durable Seroprotection: Results From the Ha Nam Cohort.
    Hoa LNM; Sullivan SG; Mai LQ; Khvorov A; Phuong HVM; Hang NLK; Thai PQ; Thanh LT; Carolan L; Anh DD; Duong TN; Bryant JE; van Doorn HR; Wertheim HFL; Horby P; Fox A
    J Infect Dis; 2022 Aug; 226(1):59-69. PubMed ID: 32484513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and immunogenicity of a cell-derived adjuvanted H5N1 vaccine - A phase I randomized clinical trial.
    Cheng A; Hsieh SM; Pan SC; Li YH; Hsieh EF; Lee HC; Lin TW; Lai KL; Chen C; Shi-Chung Chang S; Chang SC
    J Microbiol Immunol Infect; 2019 Oct; 52(5):685-692. PubMed ID: 31255574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.